University of Missouri - Columbia
Columbia, Missouri, 65211, United States
Location status: Recruiting
NCT Number: NCT03713424
This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Phase 2
Columbia, Missouri, 65211, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Entry criteria:
Inclusion criteria
all subjects:
Exclusion criteria
all subjects:
Beta lactamase inhibitor for smoking cessation
placebo
Time frame: 5 days
Biochemical smoking assessment (breath carbon monoxide) at each study visit.
Time frame: 5 Days
Number of reported side effects
Time frame: 4 days
Measure the effects of Clavulanic Acid on fMRI BOLD response to images (change from baseline to end of study) while participants undergo functional magnetic resonance imaging
Time frame: 4 days
Measure the effects of Clavulanic Acid on resting-state functional connectivity (change from baseline to end of study) while participants undergo functional magnetic resonance imaging.
Interested in participating?
Request InfoUniversity of Missouri-Columbia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07564648
Chemically-Induced Disorders, Cigarette Addiction
Columbus, Ohio, United States
View Trial DetailsNCT07812753
Behavior, Chemically-Induced Disorders
Newark, New Jersey, United States
View Trial DetailsNCT06966362
Behavior, Chemically-Induced Disorders
San Diego, California, United States
View Trial DetailsNCT06678672
Chemically-Induced Disorders, Mental Disorders
San Francisco, California, United States
View Trial Details